# Paradigm Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/paradigm-diagnostics

- Industry: Healthcare
- Headquarters: Phoenix, US
- Website: www.paradigmdx.com
- Total disclosed funding: $18M
- Latest round: Series B (May 15, 2019)
- Investors on record: 7

## About

Paradigm Diagnostics, Inc. is focused on advancing precision medicine through innovative diagnostic solutions for cancer detection, supporting clinicians and patients with actionable insights.Founded in 2012 and headquartered in Phoenix, US, Paradigm Diagnostics, Inc. specializes in cancer diagnostics. The company was acquired by Exact Sciences Corporation in March 2020, enhancing its capabilities in the oncology diagnostic space. The founder's previous endeavors are not publicly documented. Since inception, Paradigm has completed a total of 6 deals. The most recent funding round was Series B, raising USD 8.90 mn from investors including Mesa Verde Venture Partners and New Science Ventures, equaling the total amount raised to date.Paradigm Diagnostics, Inc. offers advanced diagnostic solutions aimed at cancer detection and treatment guidance. Their portfolio includes tests that analyze tumor profiles to assist healthcare providers in making informed decisions. The company primarily targets healthcare providers, patients, and researchers, with plans to expand its offerings internationally.Paradigm generates revenue through its diagnostic services provided to healthcare institutions and providers, utilizing a direct-to-consumer model as well as B2B engagements. Their pricing is structured around agreements with healthcare partners and includes billing for tests directly to providers or insurance companies, thus facilitating wider access to their offerings.Looking ahead, Paradigm Diagnostics, Inc. aims to enhance its product lineup with new diagnostic tests tailored to specific cancer types, set to launch in the coming years. The company is targeting expansion into international markets, particularly in Europe and Australia, by 2025. The recent acquisition by Exact Sciences Corporation positions Paradigm to leverage enhanced resources and expertise, which will support these initiatives effectively.

## Funding rounds

- Series B, May 15, 2019 — Tech Coast Angels, Gore Range Capital, OSF Ventures, Bluestone Venture Partners
- Series B, Jun 29, 2018, $8.9M — Mesa Verde Venture Partners, New Science Ventures
- Series B, Feb 16, 2017, $3M — New Science Ventures
- Series B, Nov 16, 2016, $3.5M — Mesa Verde Venture Partners
- Series A, May 31, 2016, $2.2M — Mesa Verde Venture Partners, New Science Ventures, Prairie Ventures

## Investors

- Mesa Verde Venture Partners (https://capitalatlas.ai/funds/mesa-verde-venture-partners) — Series A, Series B
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series A, Series B
- Prairie Ventures (https://capitalatlas.ai/funds/prairie-ventures) — Series A
- Tech Coast Angels — Series B
- Gore Range Capital (https://capitalatlas.ai/funds/gore-range-capital) — Series B
- OSF Ventures (https://capitalatlas.ai/funds/osf-ventures) — Series B
- Bluestone Venture Partners (https://capitalatlas.ai/funds/bluestone-venture-partners) — Series B